Q4 2024 111 Inc Earnings Call Transcript
Key Points
- 111 Inc (YI) achieved its first-ever operational profitability and positive operating cash flow in 2024.
- The company reduced total operating expenses by 31% year-over-year, demonstrating improved operational efficiency.
- 111 Inc (YI) expanded its digital and AI capabilities, enhancing supply chain management and customer engagement.
- The company increased its product range and improved inventory management, contributing to a 33,000 SKU expansion.
- 111 Inc (YI) strengthened its logistics network, reducing delivery times and costs, and expanded its fulfilment centers.
- Macroeconomic uncertainties in China led to cautious consumer behavior, impacting retail sales growth.
- The healthcare sector faced challenges due to ongoing reforms and regulatory changes, affecting short-term operations.
- China's total retail pharmacy sales dropped by 2.2% in 2024, intensifying competition among pharmacies.
- The aggressive expansion of pharmacies during the pandemic led to market saturation and reduced per-store revenues.
- Despite improvements, the company faced a net loss attributable to ordinary shareholders, highlighting ongoing financial challenges.
Hello everyone, and thank you for joining 111's conference call today. On the call today from the company are Dr. Gang Yu, Co-Founder and Executive Chairman, Mr. Junling Liu, Co-Founder, Chairman and CEO, Mr. Luke Chen, CFO of One's major subsidiary, and Mr. Harvey Wang, COO.
As a reminder, today's conference call is being broadcast live via webcast. The company's earnings press release was distributed earlier today, and along with the earnings presentation are available on the company's IR website.
Before the conference call gets started, let me remind you that this call may contain forward-looking statements made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1,995.
Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known and unknown risks, uncertainties, and other factors, all of which would cause actual results to differ materially. For more information about these risks, please refer to the company's filings with the SEC.
111 does not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
